Gregory R. Friberg
EVP, Chief R&D Officer, BioMarin Pharmaceutical.
Companies
- BioMarin PharmaceuticalEVP, Chief R&D Officer Oct 1, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioMarin Pharmaceutical BMRN51,818 shares2$2.8M at $54.75May 7, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 7, 2026Sold 3,281 shares at $53.85 of BioMarin Pharmaceutical2
- Mar 17, 2026Shares withheld for tax 1,629 shares at $56.05 of BioMarin Pharmaceutical3
- Mar 16, 2026Granted 19,150 shares of BioMarin Pharmaceutical3
- Feb 26, 2026Sold 6,326 shares at $60.38 of BioMarin Pharmaceutical4
- Oct 31, 2025Granted 398 shares at $45.54 of BioMarin Pharmaceutical5
- Sep 30, 2025Shares withheld for tax 3,304 shares at $54.16 of BioMarin Pharmaceutical6
- Mar 17, 2025Granted 17,750 shares of BioMarin Pharmaceutical7
- Sep 30, 2024Granted 7,870 shares of BioMarin Pharmaceutical8
- Sep 30, 2024Granted 21,190 shares of BioMarin Pharmaceutical8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 18, 2026
- 4SEC EDGARForm 4 filed Feb 26, 2026
- 5SEC EDGARForm 5 filed Feb 13, 2026
- 6SEC EDGARForm 4 filed Oct 2, 2025
- 7SEC EDGARForm 4 filed Mar 18, 2025
- 8SEC EDGARForm 4 filed Oct 1, 2024